Skip to main content
. 2018 Nov 15;9:2616. doi: 10.3389/fimmu.2018.02616

Figure 1.

Figure 1

Mechanism of daratumumab interference with the indirect antiglobulin test (IAT). (A) Negative IAT in a sample without RBC alloantibodies or daratumumab. (B) Positive IAT due to RBC alloantibodies in the sample. (C) Positive IAT due to interference from daratumumab, which binds to CD38 on RBCs and causes agglutination with the addition of Coombs reagent.